ABSTRACT
A link between chronic stress and Parkinson's disease (PD) pathogenesis is emerging. Ample evidence demonstrates that the presynaptic neuronal protein alpha-synuclein (asyn) is closely tied to PD pathogenesis. However, it is not known whether stress system dysfunction is present in PD, if asyn is involved, and if, together, they contribute to neurodegeneration. To address these questions, we assess stress axis function in transgenic rats overexpressing full-length wildtype human asyn (asyn BAC rats) and perform multi-level stress and PD phenotyping following chronic corticosterone administration. Stress signaling, namely corticotropin-releasing factor, glucocorticoid and mineralocorticoid receptor gene expression, is also examined in post-mortem PD patient brains. Overexpression of human wildtype asyn leads to HPA axis dysregulation in rats, while chronic corticosterone administration significantly aggravates nigrostriatal degeneration, serine129 phosphorylated asyn (pS129) expression and neuroinflammation, leading to phenoconversion from a prodromal to an overt motor PD phenotype. Interestingly, chronic corticosterone in asyn BAC rats induces a robust, twofold increase in pS129 expression in the hypothalamus, the master regulator of the stress response, while the hippocampus, both a regulator and a target of the stress response, also demonstrates elevated pS129 asyn levels and altered markers of stress signalling. Finally, defective hippocampal stress signalling is mirrored in human PD brains and correlates with asyn expression levels. Taken together, our results link brain stress system dysregulation with asyn and provide evidence that elevated circulating glucocorticoids can contribute to asyn-induced neurodegeneration, ultimately triggering phenoconversion from prodromal to overt PD.
Subject(s)
Corticosterone , Parkinson Disease , Rats, Transgenic , Stress, Psychological , alpha-Synuclein , alpha-Synuclein/metabolism , alpha-Synuclein/genetics , Animals , Parkinson Disease/metabolism , Parkinson Disease/pathology , Humans , Rats , Stress, Psychological/metabolism , Stress, Psychological/pathology , Male , Corticosterone/blood , Brain/metabolism , Brain/pathology , Hypothalamo-Hypophyseal System/metabolism , Female , Pituitary-Adrenal System/metabolismABSTRACT
BACKGROUND: Parkinson's disease psychosis is a prevalent yet underreported and understudied nonmotor manifestation of Parkinson's disease and, arguably, the most debilitating. It is unknown if α-synuclein plays a role in psychosis, and if so, this endophenotype may be crucial for elucidating the neurodegenerative process. OBJECTIVES: We sought to dissect the underlying neurobiology of novelty-induced hyperactivity, reminiscent of psychosis-like behavior, in human α-synuclein BAC rats. RESULTS: Herein, we demonstrate a prodromal psychosis-like phenotype, including late-onset sensorimotor gating disruption, striatal hyperdopaminergic signaling, and persistent novelty-induced hyperactivity (up to 18 months), albeit reduced baseline locomotor activity, that is augmented by d-amphetamine and reversed by classical and atypical antipsychotics. MicroRNA-mediated α-synuclein downregulation in the ventral midbrain rescues the hyperactive phenotype and restores striatal dopamine levels. This phenotype is accompanied by an abundance of age-, brain region- and gene dose-dependent aberrant α-synuclein, including hyperphosphorylation, C-terminal truncation, aggregation pathology, and mild nigral neurodegeneration (27%). CONCLUSIONS: Our findings demonstrate a potential role of α-synuclein in Parkinson's disease psychosis and provide evidence of region-specific perturbations prior to neurodegeneration phenoconversion. The reported phenotype coincides with the latest clinical findings that suggest a premotor hyperdopaminergic state may occur, while at the same time, premotor psychotic symptoms are increasingly being recognized. © 2020 International Parkinson and Movement Disorder Society.
Subject(s)
Parkinson Disease , Psychotic Disorders , Animals , Disease Models, Animal , Humans , Mice , Mice, Transgenic , Psychotic Disorders/genetics , Rats , Rats, Transgenic , Substantia Nigra/metabolism , alpha-Synuclein/genetics , alpha-Synuclein/metabolismABSTRACT
Tris-(hydroxymethyl)-aminomethane and urea were used as low-cost precursor compounds to synthesize highly fluorescent N-doped carbon nanodots (CNDs), in an environmentally-friendly, inexpensive process. The as-prepared CNDs exhibit blue fluorescence, excellent photostability under various conditions, water dispersibility and stability over several parameters, such as a wide range of pH. The N-doped CNDs were applied as a multi-probe fluorescence quenching system to the sensitive detection of nitrite (NO2-), nitrate (NO3-) and ferric (Fe3+) ions in food matrices. The recoveries from spiked food samples were fairly acceptable without significant interferences despite the complexity of the tested matrices. The decrease in fluorescence intensity is in linear relationship with the concentrations of NO2-, NO3- and Fe3+, in the ranges of 0.015-1.11 mM, 0.072-0.60 mM and 2.9-176 µΜ, respectively. The as-synthesized carbon dots were used for the detection of NO2-, NO3- and Fe3+ in food matrices after proper pretreatment, concluding that the multi-probe fluorescence system may potentially be implemented in food control. The FRET mechanism is able to describe the quenching of the CNDs-NO2- system, while the proportional temperature-dependent relationship with the slopes of calibration plots hint at a dynamic quenching mechanism. In the case of the CNDs-Fe3+ system, the slopes exhibit an inverse temperature dependence, indicating a static mechanism while there is no indication of a FRET mechanism.